Chronic Kidney Disease News

We are more than 1 year into the Medicare Kidney Care Choices model directed at patients with chronic kidney disease stages 4-5 and with end-stage kidney disease, a true test of value-based medicine.

This year, the theme of World Kidney Day is kidney health for all, and that the best way to support patients is to prepare for the unexpected.

Regardless of chronic kidney disease stage, children experience high and consistent burden of impairment across many patient-reported measures, according to data published in the American Journal of Kidney Disease.

The incidence of kidney stone recurrence did not significantly differ among patients who received hydrochlorothiazide compared with those who received placebo, according to a study published in The New England Journal of Medicine.

Following the COVID-19 pandemic, inequities regarding kidney disease treatment have worsened in low- and lower-middle income countries, according to data published in Seminar Nephrology.

Compared with Japanese patients with chronic kidney disease, Americans with CKD are more likely to experience CVD events or death before developing end-stage kidney disease, according to a published study.

Compared with warfarin, direct oral anticoagulants correlated with a reduced risk for kidney failure and declined kidney function among patients with nonvalvular atrial fibrillation, according to a retrospective study.

Patients on hemodialysis who wear Fitbits and receive structured feedback showed greater daily step counts than patients who didn’t receive coaching, according to data published in American Journal of Kidney Diseases.

Patient mortality correlated with end-stage kidney disease quality incentive program facility payment reductions in “dose-response” and temporal patterns, according to a retrospective study.

Travere Therapeutics announced the FDA granted accelerated approval to Filspari, also known as sparsentan, according to a company press release.